1,929 reports of this reaction
2.9% of all LISDEXAMFETAMINE DIMESYLATE reports
#3 most reported adverse reaction
FATIGUE is the #3 most commonly reported adverse reaction for LISDEXAMFETAMINE DIMESYLATE, manufactured by Takeda Pharmaceuticals America, Inc.. There are 1,929 FDA adverse event reports linking LISDEXAMFETAMINE DIMESYLATE to FATIGUE. This represents approximately 2.9% of all 65,887 adverse event reports for this drug.
Patients taking LISDEXAMFETAMINE DIMESYLATE who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for LISDEXAMFETAMINE DIMESYLATE, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for LISDEXAMFETAMINE DIMESYLATE:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 1,929 FDA reports for LISDEXAMFETAMINE DIMESYLATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 2.9% of all adverse event reports for LISDEXAMFETAMINE DIMESYLATE, making it one of the most commonly reported side effect.
If you experience fatigue while taking LISDEXAMFETAMINE DIMESYLATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.